These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 24259400)

  • 1. Functional expression of the capsule polymerase of Neisseria meningitidis serogroup X: a new perspective for vaccine development.
    Fiebig T; Berti F; Freiberger F; Pinto V; Claus H; Romano MR; Proietti D; Brogioni B; Stummeyer K; Berger M; Vogel U; Costantino P; Gerardy-Schahn R
    Glycobiology; 2014 Feb; 24(2):150-8. PubMed ID: 24259400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the meningococcal serogroup X capsule N-acetylglucosamine-1-phosphotransferase.
    Muindi KM; McCarthy PC; Wang T; Vionnet J; Battistel M; Jankowska E; Vann WF
    Glycobiology; 2014 Feb; 24(2):139-49. PubMed ID: 24134880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient solid-phase synthesis of meningococcal capsular oligosaccharides enables simple and fast chemoenzymatic vaccine production.
    Fiebig T; Litschko C; Freiberger F; Bethe A; Berger M; Gerardy-Schahn R
    J Biol Chem; 2018 Jan; 293(3):953-962. PubMed ID: 29187601
    [No Abstract]   [Full Text] [Related]  

  • 4. Meningococcal Factor H Binding Protein Vaccine Antigens with Increased Thermal Stability and Decreased Binding of Human Factor H.
    Rossi R; Konar M; Beernink PT
    Infect Immun; 2016 Jun; 84(6):1735-1742. PubMed ID: 27021245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and evaluation of a dipstick diagnostic test for Neisseria meningitidis serogroup X.
    Agnememel A; Traincard F; Dartevelle S; Mulard L; Mahamane AE; Oukem-Boyer OO; Denizon M; Kacou-N Douba A; Dosso M; Gake B; Lombart JP; Taha MK
    J Clin Microbiol; 2015 Feb; 53(2):449-54. PubMed ID: 25411183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neisseria meningitidis serogroup B vaccine development.
    Caesar NM; Myers KA; Fan X
    Microb Pathog; 2013 Apr; 57():33-40. PubMed ID: 23416222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cloning and functional characterization of components of the capsule biosynthesis complex of Neisseria meningitidis serogroup A: toward in vitro vaccine production.
    Fiebig T; Freiberger F; Pinto V; Romano MR; Black A; Litschko C; Bethe A; Yashunsky D; Adamo R; Nikolaev A; Berti F; Gerardy-Schahn R
    J Biol Chem; 2014 Jul; 289(28):19395-407. PubMed ID: 24849599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergence of serogroup X meningococcal disease in Africa: need for a vaccine.
    Xie O; Pollard AJ; Mueller JE; Norheim G
    Vaccine; 2013 Jun; 31(27):2852-61. PubMed ID: 23623866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The capsular polysaccharide of group B Neisseria meningitidis as a vehicle for vaccine development.
    Jennings HJ
    Contrib Microbiol Immunol; 1989; 10():151-65. PubMed ID: 2479499
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunochemical studies and genetic background of two Neisseria meningitidis isolates expressing unusual capsule polysaccharide antigens with specificities of both serogroup Y and W135.
    Tsang RS; Tsai CM; Henderson AM; Tyler S; Law DK; Zollinger W; Jamieson F
    Can J Microbiol; 2008 Mar; 54(3):229-34. PubMed ID: 18388994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The capsule polymerase CslB of Neisseria meningitidis serogroup L catalyzes the synthesis of a complex trimeric repeating unit comprising glycosidic and phosphodiester linkages.
    Litschko C; Romano MR; Pinto V; Claus H; Vogel U; Berti F; Gerardy-Schahn R; Fiebig T
    J Biol Chem; 2015 Oct; 290(40):24355-66. PubMed ID: 26286750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Escherichia coli K1 colominic acid-specific murine antibodies that are cross-protective against Neisseria meningitidis groups B, C, and Y.
    Park IH; Lin J; Choi JE; Shin JS
    Mol Immunol; 2014 Jun; 59(2):142-53. PubMed ID: 24603121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of new vaccines against meningococcal disease.
    Bröker M
    Arzneimittelforschung; 2003; 53(12):805-13. PubMed ID: 14732960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meningococcal meningitis: unprecedented incidence of serogroup X-related cases in 2006 in Niger.
    Boisier P; Nicolas P; Djibo S; Taha MK; Jeanne I; Maïnassara HB; Tenebray B; Kairo KK; Giorgini D; Chanteau S
    Clin Infect Dis; 2007 Mar; 44(5):657-63. PubMed ID: 17278055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup X.
    Micoli F; Romano MR; Tontini M; Cappelletti E; Gavini M; Proietti D; Rondini S; Swennen E; Santini L; Filippini S; Balocchi C; Adamo R; Pluschke G; Norheim G; Pollard A; Saul A; Rappuoli R; MacLennan CA; Berti F; Costantino P
    Proc Natl Acad Sci U S A; 2013 Nov; 110(47):19077-82. PubMed ID: 24191022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure of a protective epitope reveals the importance of acetylation of
    Henriques P; Dello Iacono L; Gimeno A; Biolchi A; Romano MR; Arda A; Bernardes GJL; Jimenez-Barbero J; Berti F; Rappuoli R; Adamo R
    Proc Natl Acad Sci U S A; 2020 Nov; 117(47):29795-29802. PubMed ID: 33158970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Workshop on vaccine pressure and Neisseria meningitidis, Annecy, France, 9-11 March 2005.
    Alonso JM; Gilmet G; Rouzic EM; Nassif X; Plotkin SA; Ramsay M; Siegrist CA; Stephens DS; Teyssou R; Vogel U
    Vaccine; 2007 May; 25(21):4125-9. PubMed ID: 17449149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatal Neisseria meningitidis serogroup X sepsis in immunocompromised patients in Spain. Virulence of clinical isolates.
    Vicente D; Esnal O; Pérez-Trallero E
    J Infect; 2012 Feb; 64(2):184-7. PubMed ID: 22108049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quadrivalent meningococcal conjugate vaccines.
    Pace D; Pollard AJ; Messonier NE
    Vaccine; 2009 Jun; 27 Suppl 2():B30-41. PubMed ID: 19477560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serogroup B meningococcal vaccines.
    Zimmer SM; Stephens DS
    Curr Opin Investig Drugs; 2006 Aug; 7(8):733-9. PubMed ID: 16955685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.